HK36693A - Use of ketone derivatives in the treatment of cognitive disorders - Google Patents

Use of ketone derivatives in the treatment of cognitive disorders

Info

Publication number
HK36693A
HK36693A HK366/93A HK36693A HK36693A HK 36693 A HK36693 A HK 36693A HK 366/93 A HK366/93 A HK 366/93A HK 36693 A HK36693 A HK 36693A HK 36693 A HK36693 A HK 36693A
Authority
HK
Hong Kong
Prior art keywords
treatment
cognitive disorders
ketone derivatives
ketone
derivatives
Prior art date
Application number
HK366/93A
Other languages
English (en)
Inventor
Michael Brian Tyers
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868630075A external-priority patent/GB8630075D0/en
Priority claimed from GB878726424A external-priority patent/GB8726424D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of HK36693A publication Critical patent/HK36693A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK366/93A 1986-12-17 1993-04-15 Use of ketone derivatives in the treatment of cognitive disorders HK36693A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868630075A GB8630075D0 (en) 1986-12-17 1986-12-17 Medicaments
GB878726424A GB8726424D0 (en) 1987-11-11 1987-11-11 Medicaments

Publications (1)

Publication Number Publication Date
HK36693A true HK36693A (en) 1993-04-23

Family

ID=26291706

Family Applications (1)

Application Number Title Priority Date Filing Date
HK366/93A HK36693A (en) 1986-12-17 1993-04-15 Use of ketone derivatives in the treatment of cognitive disorders

Country Status (15)

Country Link
US (1) US4845115A (ja)
EP (1) EP0275668B1 (ja)
JP (1) JP2608078B2 (ja)
KR (1) KR950013450B1 (ja)
AU (1) AU618520B2 (ja)
CY (1) CY1692A (ja)
DE (1) DE3782028T2 (ja)
DK (1) DK662687A (ja)
ES (1) ES2052585T3 (ja)
GR (1) GR3006255T3 (ja)
HK (1) HK36693A (ja)
IE (1) IE60991B1 (ja)
IL (1) IL84845A0 (ja)
NZ (1) NZ222950A (ja)
PH (1) PH25025A (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200414A (en) * 1986-12-17 1993-04-06 Glaxo Group Limited Methods for the treatment of cognitive disorders
US5190954A (en) * 1986-12-17 1993-03-02 Glaxo Group Limited Methods for the treatment of cognitive disorders
GB8805269D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments
US5229407A (en) * 1988-09-01 1993-07-20 Glaxo Group Limited Medicaments
GB8820651D0 (en) * 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
GB8914804D0 (en) * 1989-06-28 1989-08-16 Glaxo Group Ltd Process
US5225407A (en) * 1990-02-22 1993-07-06 Glaxo Group Limited 5-HT3 receptor antagonists for the treatment of autism
EP0492020A1 (en) * 1990-12-21 1992-07-01 Merrell Dow Pharmaceuticals Inc. Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders
WO1993000075A1 (en) * 1991-06-26 1993-01-07 Sepracor, Inc. Methods and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron
JPH06508836A (ja) * 1991-06-26 1994-10-06 セプラコア，インコーポレーテッド 光学的に純粋なｒ（＋）オンダンセトロンを使用する嘔吐、吐き気および他の障害の治療のための方法および組成物
AU683447B2 (en) * 1993-03-08 1997-11-13 Fujisawa Pharmaceutical Co., Ltd. Medicament for treating or preventing cerebrovascular diseases
ZA989365B (en) * 1997-10-15 1999-04-15 Boehringer Mannheim Pharm Corp Preparation for treating alzheimer's disease
ATE285235T1 (de) * 1999-01-07 2005-01-15 Gerolymatos P N Sa Verwendung von phanquinon zur behandlung und vorbeugung von gedächtnisschwund
WO2000051582A2 (en) 1999-03-01 2000-09-08 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
US20020115707A1 (en) * 2001-01-11 2002-08-22 Rami Lidor-Hadas Process for preparing pure ondansetron hydrochloride dihydrate
GB0701970D0 (en) 2007-02-01 2007-03-14 Wilson Stuart Treatment of protein aggregation diseases
US20100298397A1 (en) * 2009-05-19 2010-11-25 Singh Nikhilesh N Method of treatment of obsessive compulsive disorder with ondansetron

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531083B1 (fr) * 1982-06-29 1986-11-28 Sandoz Sa Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
FR2557110B1 (fr) * 1983-12-23 1989-11-24 Sandoz Sa Nouveaux derives d'amines cycliques, leur preparation et leur utilisation comme medicaments
NZ210940A (en) * 1984-01-25 1989-08-29 Glaxo Group Ltd 1,2,3-trihydro-3-(1h-imidazol-1-ylmethyl)-4h-carbazol-4-one derivatives and pharmaceutical compositions
DE3680123D1 (en) * 1985-01-23 1991-08-14 Glaxo Group Ltd Tetrahydrocarbazolonderivate.
US4605652A (en) * 1985-02-04 1986-08-12 A. H. Robins Company, Inc. Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
DE385517T1 (de) * 1985-03-14 1991-07-25 Beecham Group P.L.C., Brentford, Middlesex, Gb Arzneimittel zur behandlung von erbrechen.
US4624961A (en) * 1985-04-17 1986-11-25 A. H. Robins Company, Incorporated Method for enhancing memory or correcting memory deficiency with arylamidopyrazolidines and arylamidodiazabicycloalkanes
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
NL8701682A (nl) * 1986-07-30 1988-02-16 Sandoz Ag Werkwijze voor het therapeutisch toepassen van serotonine antagonisten, aktieve verbindingen en farmaceutische preparaten die deze verbindingen bevatten.

Also Published As

Publication number Publication date
AU8261487A (en) 1988-06-23
PH25025A (en) 1991-01-28
DE3782028T2 (de) 1993-02-18
KR950013450B1 (ko) 1995-11-08
AU618520B2 (en) 1992-01-02
ES2052585T3 (es) 1994-07-16
DK662687A (da) 1988-06-18
EP0275668A3 (en) 1989-10-11
JP2608078B2 (ja) 1997-05-07
US4845115A (en) 1989-07-04
EP0275668B1 (en) 1992-09-30
KR880007074A (ko) 1988-08-26
IE60991B1 (en) 1994-09-07
DK662687D0 (da) 1987-12-16
CY1692A (en) 1994-01-14
JPS63253083A (ja) 1988-10-20
NZ222950A (en) 1997-06-24
DE3782028D1 (de) 1992-11-05
IL84845A0 (en) 1988-06-30
EP0275668A2 (en) 1988-07-27
IE873414L (en) 1988-06-17
GR3006255T3 (ja) 1993-06-21

Similar Documents

Publication Publication Date Title
GB8600822D0 (en) Treatment of skin disorders
GB2190842B (en) Apparatus for the cryogenic treatment of the skin
EP0204597A3 (en) Use of alfuzosine in the treatment of urinary affections
AU6022486A (en) Apparatus for trichologic treatment of the scalp
SG96694G (en) Treatment of skin disorders
EP0275668A3 (en) Use of ketone derivatives in the treatment of cognitive disorders
EP0278173A3 (en) Use of heterocyclic derivatives in the treatment of depressions
PT84704A (en) Thiolactam-n-acetic derivatives their production and use
AU624067B2 (en) Preparation suitable for use in the treatment of enteric disorders
GB2211192B (en) Composition and process for the treatment and care of the hair
GR861024B (en) Process for the preparation of 5-pyrimidinecarboxamides and treatment of leukemia and tummors therewith
EP0235647A3 (en) Process for the manufacture of 6,13-dihydroquinacridones and quinacridones
GB2203645B (en) Improvements in the treatment of hair
GB2176104B (en) Compositions for treatment of the hair and scalp.
GB8626356D0 (en) Treatment of hair
AU4096789A (en) The use of lactam derivatives in the treatment of cognitive disorders
GB8715914D0 (en) Treatment of cerabral disorders
ZA87873B (en) Substituted diazapines and derivatives thereof useful in the treatment of cardiovascular disorders
GB8617623D0 (en) Treatment
EP0407016A3 (en) Use of benzodioxinopyrrole derivatives in the treatment of anxiety
EP0267537A3 (en) Process for the preparation of vinylglyoxal derivatives, vinylglyoxal derivatives and their use
SG4695G (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney-diseases
GB8432685D0 (en) Skin treatment cream
EP0269024A3 (en) Use of 3-methyl-4-oxothiazolidin-2-ylidene-acetamide derivatives in the treatment of aids
ZA879420B (en) 5-aryl-3h-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20041216